ADOC — Adocia SA Share News
0.000.00%
Last trade - 00:00- €82.83m
- €74.48m
- €1.48m
Brief: Adocia Initiates BC LisPram Phase 1 Clinical Trial In Pump For People With Type 1 Diabetes
Brief: Adocia Expands Clinical Development To Obesity
Brief: Adocia Q1 Revenue Down At EUR 115 Mln
Brief: Adocia FY Operating Loss Narrows To EUR 21.1 Mln
Brief: Adocia Initiates Phase 2 Clinical Trial For M1Pram
Brief: Adocia Announces Positive Clinical Results For BioChaperone Lispro
Brief: Adocia Files Patent On Hydrogen Scaffold For Type 1 Diabetes Treatment
Brief: Adocia Q3 Revenue Down At EUR 59,000
Brief: Adocia Announces Positive Topline Results Of Phase 1B Study For M1Pram
Brief: Adocia Is Granted A EUR 7 Mln State-Guaranteed Bank Loan
Brief: Adocia : Announces Initiation Of Comparative Study To Demonstrate Safety And Efficacy Of BC Lispro
Brief: Adocia H1 Net Loss Narrows To 11.9 Million Euros
Brief: Adocia Announces Positive Results Of Phase 1B Study Of ADO09
Brief: Adocia Q1 Revenues Down At 0.5 Million Euros
Brief: Adocia FY Operating Income Turns To Loss Of 22.0 Million Euros
Brief: Adocia Q3 Revenues Down At 0.2 Million Euros
Brief: Adocia Establishes Debt Financing Plan For 15 Million Euros
Brief: Adocia Announces Receipt Of 14.3 Million Dollar Payment From Eli Lilly
Brief: Adocia: previous $11.6 mln award not impacted by latest ruling in favour of Lilly